Pharsight Uses FDA Disease Model to Support Oncology Drug D...(rove every level and phase of their busi...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Pharsight Uses FDA Disease Model to Support Oncology Drug Development
Date:11/20/2007
rove every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.
Registered Trademarks and Trademarks
Pharsight is a registered trademark of Pharsight Corporation. All other brand or product names mentioned in this documentation are trademarks or registered trademarks of their respective companies or organizations.
'/>"/>
| SOURCE Pharsight Corporation Copyright©2007 PR Newswire. All rights reserved |
Related medicine technology :
1. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
4. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
5. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
6. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
7. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
8. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
9. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
10. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
11. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
Post Your Comments:
(Date:11/27/2008)...New study finds the majority of acute lymphoblasti... present at the time of diagnosis , , MEMPH...ntists at St. Jude Children,s Research Hospital ha...ancer cells of children with acute lymphoblastic l...rs a pathway to designing treatments for ALL relap...
(Date:11/26/2008)...Study Expanded to 406 Subjects , , FRANKLIN...tems Inc. (OTC Bulletin Board: PLCSF) announced to...S. Food and Drug Administration (FDA) for its U.S....ompany,s RenalGuard System(TM) and associated the...athy (CIN). , , The FDA also approved PLC,s...
(Date:11/25/2008)...Results reveal most respondents against expanding ..., , LITTLE FALLS, N.J., Nov. 25 /PRNewswire...atin may lower the cardiovascular risk of healthy ...ersal statin use in older adults, according to a n...e 1,212 participants took part in the online poll ...
(Date:11/25/2008)...SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ ...nounced that the company has completed a Phase 1,..., first-in-class,small-molecule Factor VIIa inhib...lthy volunteers to evaluate the safety and pharmac...on of PCI-27483 resulted in a linear dose,respons...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 1Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 2Eighty Nine Percent of Surveyed Rheumatologists Say They Will Prescribe Roche Chugais Actemra for Rheumatoid Arthritis 25050 3Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 1Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 2Aduromed Closes Restructuring and Raises 243 8 Million of New Equity Capital 25048 3GG One Software Announces iFastrack to Help Avoid Insurance Disasters 25046 1GG One Software Announces iFastrack to Help Avoid Insurance Disasters 25046 2Bederra Corp s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 25044 1Bederra Corp s Lumar Imaging Division Enters Into Joint Venture With Basic Solutions 25044 2[0] St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse[0] PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.[1] Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows[0] Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
... ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Study re...ospholipase A2 (Lp-PLA2), a,cardiovascular-specifi...que that can lead to heart attack and stroke, is,e...ents with the,metabolic syndrome--a serious medica...ns. The results, which were presented yesterday,at...
...OOMFIELD, N.J., March 26, 2007 /PRNewswire-FirstCa...n vivo study results,demonstrating the potential o...mall cell lung cancer (NSCLC) were recently,publis... Based on the work of Intae Lee, Ph.D., at the Uni...or Efficacy of the Cytotoxic,RNase, Ranpirnase, on...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3(Date:12/1/2008)...wswire/ -- Including a patient,s photo with imagin...g from the radiologist interpreting the images, as...according to a study presented today at the annual...ica (RSNA). , , "Our study emphasizes appr... anonymous case study," said lead author Yehonatan...
(Date:12/1/2008)...ient satisfaction scores at,outpatient health car...port,from Press Ganey Associates, Inc. The 2008 ...American Health Care cites increased competition a...tient services. The report,includes responses fr...an,1,200 outpatient care facilities nationwide la...
(Date:12/1/2008)...ew research reveals that computed tomography (CT) ...as the potential to screen for two diseases at onc...ch commonly affect adults over age 50. Results of ...eting of the Radiological Society of North America...ition to screening for colorectal cancer, we were ...
(Date:12/1/2008)..., Toy Puppies to the Obama Daughters , , WA...as been made of President-Elect Obama,s first prom...daughter,s asthma and allergies, and timing issues...on. So, in the meantime, the Asthma and Allergy F...& allergy friendly" toy puppies to the Obama c...
Breaking Medicine News(10 mins):Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 2Health News:Patient Photos Spur Radiologist Empathy and Eye for Detail 3Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis 2Health News:CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis 3Health News:Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise 2[0] Patient Photos Spur Radiologist Empathy and Eye for Detail[0] Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever[0] CT Colonography Offers One-Stop Screening for Cancer and Osteoporosis[0] Asthma and Allergy Foundation Helps New First-Dad Keep His First Promise
... doctors and nurse to avoid common errors which ef...ing hands// by the health workers help spread dise...is meant to improve patient safety around the worl... related accidents that affect millions. Patient s...
...areas have had enough. Most Doctors are on the bri...//. A survey conducted by the Australian Medical A...f the stress because of the staff shortage, outdat...agues from abroad. In the rural area many hospita...
...-feeding, there is no hard and fast rule as to how...hers would be more// than glad to endorse that vie... breast feeding, can prove too painful for motherl...of Nicola Adolphe. Nicola accordingly, had a horre...
... diabetes is fast becoming a common reason for mal...ctive Medicine Research Group at Queen's Universit...ples of 57 men who were diagnosed with Diabetes Ty...rom birth, the body does not produce the hormone i...
Other Medicine News:Health News:UN Agency’s Checklist on Health Care Erro 2Health News:New Research Promises To Take The Pain Off Breast Feeding 2Health News:New Research Promises To Take The Pain Off Breast Feeding 3Health News:Fertility Rates Felled By Diabetes 2Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...Ulti-Mist™ HME product line has the right pr...dults and from intubated patients to patients with...dification for both anesthesia and critical care a...provide maximum protection for patients and staff ...
...e hygroscopic condenser humidifiers (HCH) capture ... them in the inspired gas. Small and compact, they...nd hygroscopic benefits. Depending on the tidal vo...l-volume model., ,The adult HCH is ideal for pati...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |